Haiwen Chen
State Key Laboratory Of Respiratory Disease
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A recurrence risk prediction model and recurrence patterns in pulmonary lymphoepithelial carcinoma based on clinical and dynamic hematologic parameters.
Journal: Translational lung cancer research
Published: February 17, 2026
Induction chemoradiotherapy achieves long-term recurrence-free survival in locally advanced pulmonary lymphoepithelioma-like carcinoma: a case report and literature review.
Journal: Frontiers in immunology
Published: April 04, 2025
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 02, 2022
KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China.
Journal: Translational lung cancer research
Published: July 19, 2022
EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression.
Journal: Cancer immunology research
Published: May 10, 2022
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.
Journal: Journal of virology
Published: March 29, 2022
Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses.
Journal: Viruses
Published: September 21, 2021
EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.
Journal: Cancer research
Published: July 14, 2021
T cell epitope screening of Epstein-Barr virus fusion protein gB.
Journal: Journal of virology
Published: March 04, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026